Goldtent TA Paradise

NIPAH VIRUS IN INDIA

1. Fullgoldcrown says:

   September 17, 2023 - 10:19 am at 10:19 am

   ou’re not going to believe this story, but here we go again. Just wait till you see all the connecting parts. We’ll begin with a Hindustan Times story that ran yesterday headlined, “Nipah virus: Health department tightens restrictions in Kerala.” Yep. They’re doing it again.

   image.png
   Kerala is an urban political region in southwest India where 33 million people live. The Kerala region is subdivided into about 22,000 tiny ‘wards’, which are comparable to village or neighborhood councils. Wards typically contain between 5,000 and 20,000 people.

   image 6.png
   Nipah virus is a relatively-new, high-fatality respiratory virus that first appeared in India back in 2001. It’s a nasty bug. It features a startling 40%-75% mortality rate, is rated for BSL-4, the highest biolab security requirement, and is a CDC designated “Bioterrorism Agent.” Articles describing the current two human deaths variously suggest a zoonotic (animal) origin for the virus either from pigs or, wait for it, fruit bats.

   It reportedly spreads through body fluids.

   Nipah virus is NOT airborne. Of course, that’s not stopping everybody in Kerala from maniacally wearing masks because, why would it? Masks can stop any kind of virus using their magical mask powers. You just have to make the right sacrifices to the mask gods, or something.

   Two deaths is not an outbreak. The official alarm seems to stem from the fact that the second guy who died was contact traced to the first victim. The second guy ran into the first guy at the hospital, which strongly suggests human-to-human transmission. And that’s what has everyone so excited.

   One case of human transmission.

   In spite of the fact that all post-pandemic studies of lockdowns concluded lockdowns don’t work, and cause enormous unintended harms, the article reported that India’s health ministry has already declared 45 Kerala wards as a “containment zone” after discovering the two Nipah deaths. The containment order imposed a useless lockdown, restricting access to the 45 wards, shuttering schools, prohibiting public gatherings, nixing “non-essential” businesses, mandating masks, requiring testing and tracing, and setting a 5pm curfew.

   It was not clear from the Hindustan Times article (or any of the other articles) how India’s ministry of health concluded that a lockdown was needed for a non-airborne virus. Apparently you don’t even need to explain it anymore.

   In case you are germaphobically fretting over this new viral threat, don’t worry! Just last year in July, Moderna and Fauci’s NIAID started a clinical trial for a new mRNA vaccine for … the Nipah virus! What good luck!

   But wait, there’s more. Almost exactly two years ago, researchers published a study on arXiv concluding they’d found Indian-origin Nipah virus DNA in, get this, the five original covid-19 patients at the Wuhan Institute of Virology (WIV) lab.

   image 3.png
   The researchers were astonished finding Nipah virus where it shouldn’t be, because it proved “that research at WIV was being conducted on an assembled infectious clone.” This was so astonishing because the BSL-3-rated Wuhan lab wasn’t supposed to be working on any BSL-4-level viruses:

   Research involving Nipah [NiV] infectious clones has never been reported to have occurred at the WIV… [these findings] indicate that research at WIV was being conducted on an assembled NiV infectious clone. Contamination of patient sequencing reads by an infectious NiV clone of the highly pathogenic Bangladesh strain could indicate a significant breach of BSL-4 protocols. We call on WIV to explain the purpose of this research on infectious clones of Nipah Virus, the full chronology of this work, and to explain how and at what stage of sample preparation this contamination occurred.

   I’ll give you two guesses. Which do you think happened: one, the Wuhan lab was immediately forced to explain why it was secretly experimenting on a dangerous potential bioweapon like Nipah, or two, everybody completely ignored this shocking 2021 study?

   Yep. It was two. But the story didn’t completely die. One year later in 2022, Congress heard testimony that the Wuhan lab was experimenting on Nipah. Here’s the headline from the Washington Times’ August 9th, 2022 article:

   image 7.png
   The article reported that a Senate subcommittee on emerging threats took testimony from a scientific witness, Dr. Steven Quay, who testified the Wuhan Institute of Virology was carrying out synthetic biology research on the Nipah virus genome in December 2019, right around the same time the first covid-19 cases surfaced in Wuhan.

   Dr. Quay was blunt. He accused the WIV of bioengineering Nipha. He told Senators, “Nipah is a BSL-4 level pathogen and a CDC-designated bioterrorism agent. This is the most dangerous gain-of-function research I have ever encountered. We should assume this research continues to this day at the WIV.”

   But it gets better. In 2021, around the same time Fauci’s NIAID started working with Moderna to trial a Nipah mRNA vaccine, Fauci also awarded a separate $2.3 million dollar grant to study the Nipah virus in bats, and guess who he awarded the grant to?

   image 4.png
   Yep. Peter Daszak of EcoHealth Alliance, who at the time was up to his dirty, bioweapons money-laundering neck in the covid disaster. And … bats again. They love the bat viruses. Someday we’ll figure out why.

   But wait… the story gets even better! Guess what particular medication that, in 2019, the NIH found was allegedly “completely protective” against Nipah? Hint: Fauci loves this medication. Yep. You guessed it. Run-death-is-near:

   image 8.png
   Are you feeling the Dejá vu yet? Next, consider this: In May 2018, Johns Hopkins ran one of its now-infamous “tabletop exercise” planning sessions, this time using a bioengineered Nipah-Flu combo virus as the simulation’s subject.

   The last line in the event’s description was the most chilling:

   image 5.png
   As a lawyer, I would call it “real world evidence” that there’s a study and testimony proving the Wuhan lab — which used gain-of-function techniques to engineer the covid virus by making it more transmissible in humans — was (or is) also working on gain of function on the Nipah virus.

   I’m telling you, these health bureaucrats and experts are going to get us all killed one of these days.

   THE BOTTOM LINE

   Wild-type Nipah is not a pandemic candidate, for two good reasons, First, it has a too-high fatality rate. People get too sick too fast for it to spread efficiently. Second and more important, Nipah isn’t airborne. Transmission requires physical contact, which means: no super-spreading.

   It’s true that could change if a new weaponized version of the virus suddenly appears, but that hasn’t happened yet. India’s been dealing with small Nipah outbreaks like this for twenty years since 2001, and newspapers have been wrongly predicting Nipah pandemics all that time.

   Based on what we know, it looks more like India is overreacting than anything else. If and when it looks like the usual suspects will try knitting Nipah into a pandemic, then I’ll offer suggestions for how we should respond. But, in yet another coincidence, I have seen at least one published study suggesting ivermectin is effective against the family of viruses that includes Nipah. You might want to order yourself a couple boxes.

   For now, the real story is not India The real story is Wuhan: the Wuhan lab is experimenting with Nipah! That should be a four-alarm fire. And the NIH is funding it! Our representatives need to pull the plug for good on our uselessly-dangerous big health agencies, and we need to shut down that lab in Wuhan before something worse than covid happens.